DENSO Robotics is a market leader in small industrial robots. 4, 5- and 6-axis robots, collaborative, pharmaceutical and small gantry type robots. Read more: Roboter klein
Some of the benefits of automation include efficiency, saving workers from hazardous environments or repetitive tasks, reducing training overhead, eliminating human error, increasing repeatability and reproducibility, and in cleanrooms, removing the potential for human contamination.
[141 Pages Report] The overall pharmaceutical robotic systems market is expected to grow from USD 64.37 million in 2016 to USD 119.46 million by 2021, at a CAGR of 13.2% from 2016 to 2021.Benefits offered by robotic systems in pharmaceutical manufacturing is a key factor driving the growth of pharmaceutical robots market.
The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.Market Dynamics1.
Benefits offered by robotic systems in pharmaceutical manufacturing2.
Conferences and exhibitions to raise awareness of robotic systems in pharmaceutical manufacturingRobotic systems provide various benefits to pharmaceutical manufacturing such as lesser space utilization, reduced production downtime, no labor turnover, enhanced health and safety, better waste management, increased production flexibility, improved production output and product quality, and lower operating costs.
With the growing pharmaceutical industry and the various benefits offered by robotic automation, the adoption of robots is likely to increase in the coming years.Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=210985096On the basis of application, the global pharmaceutical robotic systems market is segmented into picking and packaging, inspection of pharmaceutical drugs, and laboratory applications.
Robotic systems provide various benefits to pharmaceutical manufacturing such as lesser space utilization, reduced production downtime, no labor turnover, enhanced health and safety, better waste management, increased production flexibility, improved production output and product quality, and lower operating costs.
With the growing pharmaceutical industry and the various benefits offered by robotic automation, the adoption of robots is likely to increase in the coming years.
[141 Pages Report] The overall pharmaceutical robotic systems market is expected to grow from USD 64.37 million in 2016 to USD 119.46 million by 2021, at a CAGR of 13.2% from 2016 to 2021.Benefits offered by robotic systems in pharmaceutical manufacturing is a key factor driving the growth of pharmaceutical robots market.
The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.Market DynamicsBenefits offered by robotic systems in pharmaceutical manufacturingConferences and exhibitions to raise awareness of robotic systems in pharmaceutical manufacturingA robotic system is a type of automation that has multiple axes of motion and can be programmed to perform a function.
Some of the benefits of automation include efficiency, saving workers from hazardous environments or repetitive tasks, reducing training overhead, eliminating human error, increasing repeatability and reproducibility, and in cleanrooms, removing the potential for human contamination.Get a sample PDF copy of the Report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=210985096On the basis of application, the global pharmaceutical robotic systems market is segmented into picking and packaging, inspection of pharmaceutical drugs, and laboratory applications.
The picking and packaging segment accounted for the largest share of the global pharmaceutical robotic systems market.